{"contacts": [{"terms": [{"accession": "MS:1000586", "name": "contact name", "value": "iolanda Vendrell"}, {"accession": "MS:1000589", "name": "contact email", "value": "iolanda.vendrell@oncology.ox.ac.uk"}, {"accession": "MS:1000590", "name": "contact affiliation", "value": "CRUK-MRC Oxford Institute for Radiation Oncology, Oxford University"}, {"accession": "MS:1002037", "name": "dataset submitter"}]}, {"terms": [{"accession": "MS:1002332", "name": "lab head"}, {"accession": "MS:1000586", "name": "contact name", "value": "Eric O'Neil"}, {"accession": "MS:1000589", "name": "contact email", "value": "eric.oneill@oncology.ox.ac.uk"}, {"accession": "MS:1000590", "name": "contact affiliation", "value": "Dept. of Oncology, University of Oxford, Oxford, OX3 7DQ, UK"}]}], "datasetFiles": [{"accession": "PRIDE:0000409", "name": "Peak list file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD012694/HF0086_MSQ512_DanielaP_20160219_OncP008_1_pcDNA3.mgf"}, {"accession": "PRIDE:0000409", "name": "Peak list file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD012694/HF0086_MSQ512_DanielaP_20160219_OncP008_2_Rassf1A.mgf"}, {"accession": "PRIDE:0000408", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD012694/HF0086_MSQ512_BCF_P008_1_pcDNA3_F189077.xml"}, {"accession": "PRIDE:0000408", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD012694/HF0086_MSQ512_BCF_P008_2_Rassf1A_F189078.xml"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD012694/HF0086_MSQ512_DanielaP_20160219_OncP008_1_pcDNA3.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD012694/HF0086_MSQ512_DanielaP_20160219_OncP008_2_Rassf1A.raw"}], "description": "Lung cancer remains the leading cause of cancer-related death due to poor treatment responses and resistance arising from tumor heterogeneity. Here we show that adverse prognosis associated with epigenetic silencing of the tumour suppressor RASSF1A is due to increased deposition of extracellular matrix (ECM), tumour stiffness and metastatic dissemination in vitro and in vivo. We find that lung cancer cells with RASSF1A promoter methylation display constitutive nuclear YAP1 and expression of collagen prolylhydroxylase (P4HA2) which increases collagen deposition. Furthermore, we identify that elevated collagen creates a stiff-ECM which in turn triggers cancer stem-like programming and metastatic dissemination in vivo. Re-expression of RASSF1A or inhibition of P4HA2 activity reverse these effects and increase markers of lung differentiation (TTF-1, Mucin5B). Our study identifies RASSF1A as a clinical biomarker associated with mechanical properties of ECM which increases levels of cancer stemness and risk of metastatic progression in lung adenocarcinoma. Moreover, we highlight P4HA2 as a potential target for uncoupling ECM signals that support cancer stemness.", "fullDatasetLinks": [{"accession": "PRIDE:0000411", "name": "Dataset FTP location", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/05/PXD012694"}, {"accession": "MS:1001930", "name": "PRIDE project URI", "value": "http://www.ebi.ac.uk/pride/archive/projects/PXD012694"}], "identifiers": [{"accession": "MS:1001919", "name": "ProteomeXchange accession number", "value": "PXD012694"}], "instruments": [{"accession": "MS:1001911", "name": "Q Exactive"}], "keywords": [{"accession": "MS:1001925", "name": "submitter keyword", "value": "cancer stem cells, Hippo pathway, stiffness, extracellular matrix."}], "modifications": [{"accession": "PRIDE:0000398", "name": "No PTMs are included in the dataset"}], "publications": [{"terms": [{"accession": "MS:1000879", "name": "PubMed identifier", "value": "31133556"}, {"accession": "PRIDE:0000400", "name": "Reference", "value": "Pankova D, Jiang Y, Chatzifrangkeskou M, Vendrell I, Buzzelli J, Ryan A, Brown C, O'Neill E. RASSF1A controls tissue stiffness and cancer stem-like cells in lung adenocarcinoma. EMBO J. 2019"}]}], "species": [{"terms": [{"accession": "MS:1001469", "name": "taxonomy: scientific name", "value": "Homo sapiens (Human)"}, {"accession": "MS:1001467", "name": "taxonomy: NCBI TaxID", "value": "9606"}]}], "title": "RASSF1A controls Tissue Stiffness and Cancer Stem-like Cells in Lung Adenocarcinoma"}